Managing allergy to heparins;Was tun bei heparinallergie?

Deutsches Arzteblatt

Volumn 103, Issue 43, 2006, Pages

  Gaigl, Zeno ^a   Klein, C Eberhard ^b   Großmann, Ralf ^a   Pfeuffer, Petra ^a   Raith, Petra ^a   Bröcker, Eva B ^a   Trautmann, Axel ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Praxis für Dermatologie Phlebologie und Allergologie ^*  (Germany)

^c Klinik und Poliklinik für Dermatologie Venerologie und Allergologie   (Germany)

Author keywords

Delayed hypersensitivity reaction; Heparin; Heparin induced skin necrosis; Heparinoid; Provocation test

Indexed keywords

HEPARIN;

ALLERGIC REACTION; ALLERGY; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ECZEMA; HUMAN; INJECTION SITE; REVIEW; SKIN TEST;

EID: 33751517690     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Klein GF, Kofler H, Wolf H, Fritsch PO: Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy. J Am Acad Dermatol 1989; 21: 703-7.
2. Trautmann A: Heparinallergie. In: Trautmann A: Allergiediagnostik, Allergietherapie. Stuttgart, New York: Thieme 2006; 246-9.
3. Estrada Rodriguez JL, Gozalo RF, Ortiz DU, Matilla B, Rodriguez Prieto MA, Gonzalez Moran NA: Generalized eczema induced by nadroparin. J Investig Allergol Clin Immunol 2003; 13: 69-70.
4. Greiner D, Schöfer H: Allergisches Arzneimittelexanthem auf Heparin. Hautarzt 1994; 45: 569-72.
5. Warkentin TE, Roberts RS, Hirsh J, Kelton JG: Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest 2005; 127: 1857-61.
6. Greinacher A, Lubenow N, Hinz P, Ekkernkamp A: Heparininduzierte Thrombozytopenie. Dtsch Arztebl 2003; 100(34-35): A 2220-9.
7. Boehncke WH, Weber L, Gall H: Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis 1996; 35: 73-5.
8. Trautmann A, Bröcker EB, Klein CE: Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug. Contact Dermatitis 1998; 39: 43-4.
9. Jappe U, Reinhold D, Bonnekoh B: Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration. Contact Dermatitis 2002; 46: 29-32.
10. Gaigl Z, Pfeuffer P, Raith P, Bröcker EB, Trautmann A: Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Br J Haematol 2005; 128: 389-2.
11. Bruze M, Isaksson M, Edman B, Björkner B, Fregert S, Möller H: A study on expert reading of patch test reactions: inter-individual accordance. Contact Dermatitis 1995; 32: 331-7.
12. Mendez J, Sanchis ME, de la Fuente R, Stolle R, Vega JM, Martinez C et al.: Delayed-type hypersensitivity to subcutaneous enoxaparin. Allergy 1998; 53: 999-1003.
13. Kroon C, de Boer A, Kroon JM, Schoemaker HC, van den Meer FJ, Cohen AF et al.: Influence of skinfold thickness on heparin absorption. Lancet 1991; 337: 945-6.
14. Schiffner R, Glassl A, Landthaler M, Stolz W: Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids. Contact Dermatitis 2000; 42: 49.
15. Lindhoff-Last E, Kreutzenbeck HJ, Magnani HN: Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost 2005; 93: 63-9.
16. Grassegger A, Fritsch P, Reider N: Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001; 27: 47-52.
17. Ludwig RJ, Beier C, Lindhoff-Last E, Kaufmann R, Boehncke WH: Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003; 49: 158-9.
18. Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH: Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb Haemost 2005; 94: 1265-9.
19. Utikal J, Peitsch WK, Booken D, Velten F, Dempfle CE, Goerdt S et al.: Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy. Thromb Haemost 2005; 94: 895-6.
20. Hirsch K, Ludwig RJ, Lindhoff-Last E, Kaufmann R, Boehncke WH: Intolerance of fondaparinux in a patient allergic to heparins. Contact Dermatitis 2004; 50: 383-4.
21. Hohenstein E, Tsakiris D, Bircher AJ: Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux. Contact Dermatitis 2004; 51: 149-51.
22. Maetzke J, Hinrichs R, Staib G, Scharffetter-Kochanek K: Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004; 59: 237-8.
23. Kam PC, Kaur N, Thong CL: Direct thrombin inhibitors: pharmacology and clinical relevance. Anaesthesia 2005; 60: 565-74.
24. Schrör K: Hämostaseologie. Internist 2005; 46: 873-81.
25. Hyers TM: Management of venous thromboembolism: past, present, and future. Arch Intern Med 2003; 163: 759-68.